Granite Point Capital Management’s CareDx CDNA Stock Holding History

Granite Point Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-140,000	Closed	-$10.1M	–	183
2020 Q4	$10.1M	Buy	140,000 +80,000	+133%	+$4.64M	0.52%	18
2020 Q3	$2.28M	Buy	60,000 +20,000	+50%	+$675K	0.12%	87
2020 Q2	$1.42M	Hold	40,000	–	–	0.07%	99
2020 Q1	$873K	Sell	40,000 -74,722	-65%	-$1.67M	0.49%	50
2019 Q4	$2.48M	Buy	114,722 +53,562	+88%	+$1.23M	0.39%	34
2019 Q3	$1.38M	Hold	61,160	–	–	0.22%	37
2019 Q2	$2.2M	Hold	61,160	–	–	0.15%	42
2019 Q1	$1.93M	Hold	61,160	–	–	0.19%	46
2018 Q4	$1.54M	Hold	61,160	–	–	0.31%	44
2018 Q3	$1.76M	Hold	61,160	–	–	0.12%	65
2018 Q2	$749K	Sell	61,160 -93,340	-60%	-$1.07M	0.07%	89
2018 Q1	$1.23M	Sell	154,500 -35,500	-19%	-$219K	0.12%	53
2017 Q4	$1.4M	Buy	+190,000	New	+$1.18M	0.14%	44

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Granite Point Capital Management's CDNA Position: Q1 2021 in Review

Granite Point Capital Management sold out of CareDx (CDNA) in Q1 2021, closing a stake of 140,000 shares — an estimated $10.1M sold.

Granite Point Capital Management first reported a position in CDNA in Q4 2017 and held it in 13 quarters. The position peaked at $10.1M in Q4 2020. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

Granite Point Capital Management reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
Granite Point Capital Management sold 140,000 CareDx shares in Q1 2021, an estimated $10.1M.
Granite Point Capital Management first reported a position in CareDx in Q4 2017 and held it in 13 quarters.
Granite Point Capital Management's CareDx position peaked at $10.1M in Q4 2020.
245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Granite Point Capital Management's 13F filing for Q1 2021, filed 12 May 2021.